Second cases are rare, but the numbers appear to be ticking up.
, the answer is more than a little murky. “You really need to have a cohort of people who are well followed and tested every time they have symptoms,” says Caroline Quach-Thanh, an infectious diseases specialist at CHU Sainte-Justine, a pediatric hospital at the University of Montreal.
, scientists report in a preliminary study posted May 3 at medRxiv.org . Quach-Thanh has seen an even smaller rate in her own study of health care workers first infected between March and September of 2020. Those data are still unpublished, but she points out that most of the people in her study were vaccinated. “A natural infection with three doses of vaccines protects better than just a natural infection,” she says.
When you get reinfected, you might [have symptoms] like a cold, or even sometimes a cough, and a little bit of a fever, but you usually don’t progress to complications as much as you would with your first infection — if you’re vaccinated.: I think that’s unknown, but it’s being studied.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer says tweaked COVID-19 shots boost omicron protectionPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
Lire la suite »
Pfizer says tweaked Covid-19 shots boost omicron protectionThe announcement comes days before an FDA advisory committee meeting to discuss whether to offer updated boosters to Americans this fall.
Lire la suite »
San Francisco Pride Parade Returns After COVID-19 HiatusHundreds of thousands of LGBTQ community members and allies gathered to march down Market Street in San Francisco Sunday in a parade so packed that it stretched for hours.
Lire la suite »
Pfizer says its tweaked COVID-19 shots boost protection against the omicron variantPfizer said that tweaking its vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
Lire la suite »
Pfizer says tweaked COVID-19 shots boost omicron protectionPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
Lire la suite »
COVID-19 Positive Patients at Far Higher Risk of Developing Serious Neurodegenerative DisordersCOVID-19 positive outpatients are at a far increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown. The research study, which analyzed the health record
Lire la suite »